461 related articles for article (PubMed ID: 32353489)
1. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
2. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
3. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
[TBL] [Abstract][Full Text] [Related]
4. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
[No Abstract] [Full Text] [Related]
5. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
[TBL] [Abstract][Full Text] [Related]
6. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
7. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
10. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
12. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
13. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
14. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.
Dicker AJ; Crichton ML; Pumphrey EG; Cassidy AJ; Suarez-Cuartin G; Sibila O; Furrie E; Fong CJ; Ibrahim W; Brady G; Einarsson GG; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
J Allergy Clin Immunol; 2018 Jan; 141(1):117-127. PubMed ID: 28506850
[TBL] [Abstract][Full Text] [Related]
15. The sputum microbiome is distinct between COPD and health, independent of smoking history.
Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
[TBL] [Abstract][Full Text] [Related]
16. Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup.
Diver S; Richardson M; Haldar K; Ghebre MA; Ramsheh MY; Bafadhel M; Desai D; Cohen ES; Newbold P; Rapley L; Rugman P; Pavord ID; May RD; Barer M; Brightling CE
Allergy; 2020 Apr; 75(4):808-817. PubMed ID: 31556120
[TBL] [Abstract][Full Text] [Related]
17. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
[No Abstract] [Full Text] [Related]
18. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
20. Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations.
Mao X; Li Y; Shi P; Zhu Z; Sun J; Xue Y; Wan Z; Yang D; Ma T; Wang J; Zhu R
Microb Pathog; 2023 Nov; 184():106335. PubMed ID: 37673353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
